RTI Surgical® Schedules Fourth Quarter and Full Year 2018 Earnings Call for February 28, 2019
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced […]
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — RTI Surgical, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced […]
– Strong Launch of TIBSOVO® Continues with Net Revenue of $9.4M for the Fourth Quarter and $13.8M for Full Year […]
BUFFALO, N.Y., Feb. 14, 2019 (GLOBE NEWSWIRE) — Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, […]
Highlights include: Record annual sales of $3.0 billion for 2018, up 8% from 2017 2018 operating margin of 10.5%, up […]
REDWOOD CITY, Calif., Feb. 14, 2019 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that […]
— First Patient Dosed in University of Chicago Phase 2a Trial of EDP1503 in Metastatic Melanoma —— Preclinical Studies Have […]
Conference Call and Webcast Scheduled for Tuesday, February 19, 2019 at 8:00 a.m. ET MALVERN, Pa., Feb. 14, 2019 (GLOBE […]
WATERTOWN, Mass., Feb. 14, 2019 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and […]
HOUSTON, Feb. 14, 2019 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, announced that the company has […]
ALACHUA, Fla., Feb. 14, 2019 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative […]